hey. i can't believe people are that dumb. seriously.
hey. i can't believe people are that dumb. seriously. moronic really. but its their money (energy). so i have to believe that they are flipping. want shares cheaper or something. fine by me. like i said, i don't care what others do. i do my research. invest accordingly. my research doesn't come from mbs
the 2nd hilarity is hypocrisy. i saw people blaming other posters (on this board. mentioning names from other, non inv hangout boards too i suspect. idk for sure). but apparently attacking people who were trying to support their investment. people that were labeled as "pumpers"
some seemed almost to suggest these people "clicked their buy button". "pumped" the stock. "forcing" them to buy
so, if true
why "bash"? and worse, think it without consequence? (meaning, how can it be true one way and not the other) think about it
personally, everyone should do what they like. but, what sense does that make? meaning, you bought into a "pump" (and take no responsibility for your buy). then "bash" (xtreme opposite of pumping right?), and take no responsibility for the effects on the pps there either
oh brother. one way or the other. not both (if "pumping" made buyers, why is it hard to understand that "bashing" makes sellers)
ha-haaaa. lol. in what universe? swear this crap is true. though hard to believe
hypocrisy. wrapped in ignorance. cloaked in stupidity (that's why i have to assume it is flippers doing their thing
for those who insist. can't help themselves. and claim to be "long"
i have the solution. sell. move on. sell is what i'd say to those who can't help themselves. with "psychologic problems". nothing good to say
how does ranting and raving over every tick help your investment? state of mind? energy? doesn't it seem obvious to everyone else? is that the best you can do? if you don't like your position (and invested your energy/money into an investment vehicle), then change it. bashing it (and negatively impacting your position) makes little sense. they're bashing their own dollars. cray-cray
who does this? not anyone thinking rationally. but hey, maybe that's why some have "psychologic problems"... just like the poster said
is there not a better use of their time? energy? money? if you already have money in the stock, can you find a more productive way to spend your time? rather than attack the monies you've already put into it? common sense (why devalue your own funds. capital. resources)
why would anyone beat up their own position?
beyond me. but also hilariously funny. people making no sense. acting irrationally pretending they're perfectly fine. everyone else is to be blamed
wow. just wow
Nanotech Entertainment Inc. (NTEK) Stock Research Links
Scroll down for more posts ▼
Top 10 Most Recent News Articles
Trash is a lousy place to look for technological glamour, which is precisely why DataBeyond's COP31 appearance deserves a sober look. On November 19 in Antalya, Türkiye, the Hangzhou-based equipment provider used a China Pavilion event to lay out its case for AI, optical sensing and robots in resource recovery. That is not a magic-green headline. It is a practical...
Continue Reading
Ankles leave little clues after a long day: sock grooves, puffiness, that dull heaviness nobody bothers to name. PureHealth Research wants people to look past the usual salt-and-water explanation and consider the lymphatic system, the body’s comparatively unsung network for gathering fluid from tissues and returning it to the bloodstream. Fair enough. This system does...
Continue Reading
A bucket of paint rarely sounds strategic until it sits inside a regional supply chain. That is the useful part of 3TREES chairman and president Hong Jie's message from the Asia-Pacific Economic Cooperation CEO Summit in Shenzhen on November 17-18, 2026: coatings are not merely a commodity if the supplier can bring materials, energy savings, technical know-how and...
Continue Reading
A Collar Gadget Is Chasing the Empty-House Problem Leave a dog or cat alone for a few hours and plenty of owners turn into amateur detectives. Did the cat eat? Has the dog been pacing? Why was that one weird noise caught on the home camera? Seattle startup PettiChat is trying to turn that itch into a product category with PettiLive!, a screen-based version of a pet that...
Continue Reading
A holiday spectacle can outlive the hands that hung its first bulb. Riverside is about to test that truth in public, under millions of tiny lights and the very large shadow of a family departure. The Mission Inn Festival of Lights returns in 2026 without Kelly and Duane Roberts as hotel owners for the first time in more than three decades. Duane Roberts died in 2025, the...
Continue Reading
Archives usually get applause only after somebody realizes a piece of history has vanished. Ajman is trying to skip that miserable part. During the Ajman Media Forum 2026, held November 18 and 19 at the Emirates Hospitality Centre, the emirate launched Ajman Memory, a project built to collect, document and preserve photographs, papers and video recording its development....
Continue Reading
Allergy Workflows Are Where This Has to Earn Its Keep Allergy clinics do not need another shiny dashboard clogging up a workstation. They need less typing, fewer handoffs, cleaner documentation, and fewer administrative chores slipping through the cracks while a packed day keeps moving. That is the practical lens for ModuleMD's ACAAI 2026 presentation in Phoenix: not...
Continue Reading
Concrete work is where space ambition stops being a brochure. Isar Aerospace has taken operational responsibility for its dedicated launch infrastructure at Spaceport Nova Scotia, and construction is beginning on the Canadian launch pad it will use. For Maritime Launch Services, this is the sort of update that deserves more than the usual starry-eyed applause. A Site...
Continue Reading
Nothing says a feverish new listing quite like leveraged products lining up before the opening-week confetti has settled. Anthropic priced its IPO at $83 on November 18, raised roughly $81.3 billion, then opened Nasdaq trading at $111.50 on November 19. That is an enormous gap between IPO price and first trade, and it tells investors the obvious thing: plenty of appetite...
Continue Reading
A trade-show order book is not cash in the bank, but 150 MW is still a number worth circling in red. PHONO used RE+ 2026 in Las Vegas, held November 17 through 19, to celebrate 20 years in business, parade its solar and storage lineup, and announce new U.S. orders. In a solar market that has become touchier about provenance, compliance and delivered economics, the company...
Continue Reading
Top 5 Most Recently Viewed Articles
HCW Biologics Unveils Innovative Treatments for Solid Tumors HCW Biologics Inc., a clinical-stage biopharmaceutical company, recently announced important developments in its research on second-generation, multi-specific T-cell engagers. These therapies specifically target solid tumors, notably pancreatic cancer, utilizing the company's proprietary TRBC product discovery...
Continue Reading
Overview of the Small Cap Growth Virtual Investor Conference The Small Cap Growth Virtual Investor Conference is set to take place soon, bringing together a diverse group of companies and investors. This exciting virtual event will provide a platform for companies to showcase their offerings to interested investors from various backgrounds. The conference promises an...
Continue Reading
Introduction to Crexi Auction's 2025 Performance As the landscape of commercial real estate evolves, Crexi Auction stands out with remarkable performance metrics indicating a strong rebound in market confidence. Recent reports highlight a 96% close rate for Crexi Auction during the first half of the year, showcasing a notable 10% year-over-year increase in transaction...
Continue Reading
Digihost and NANO Nuclear Join Forces for Renewable Energy Digihost Technology Inc. and NANO Nuclear Energy Inc. have united to submit a proposal to the New York State Energy Research and Development Authority (NYSERDA). Their aim? To facilitate the development of cutting-edge, clean energy solutions that will revolutionize New York's energy landscape. This collaboration...
Continue Reading
Syndax Pharmaceuticals (NASDAQ: SNDX) and Its Market Journey Syndax Pharmaceuticals Inc. (NASDAQ: SNDX) has recently made headlines as its stock price has fallen to a 52-week low of $12.75. This decline is indicative of the current hurdles the biopharmaceutical company is facing in a challenging market landscape. Investors have noted that the stock is currently in an...
Continue Reading